Dr. Rodney Breau is a Surgical Oncologist, an Assistant Professor of Urology at The University of Ottawa, and an Associate Scientist at the Ottawa Hospital Research Institute. He attended medical school at Dalhousie University and urology residency at the University of Ottawa. He completed his Urologic Oncology and Robotic Surgery Fellowship at Mayo Clinic and received a Master of Science in Clinical and Translational Research from Mayo School of Graduate Medical Education.
Dr. Breau is a founding member of the International Evidence Based Urology Group and serves on the American Urological Association steering committee for Evidence Based Reviews in Urology. He is a member of the Society of Urologic Oncology and has been recognized nationally and internationally for research contributions in prostate, kidney and bladder cancer.
Breau RH, Kokolo MB, Punjani N, Cagiannos I,
Beck A, Niznick N, Buenaventura C, Cowan J, Knoll G, Momoli F, Morash C,
Ruzicka M, Schachinka S, Tinmouth A, Xie HY, and Fergusson DA. Efficacy and safety
of lysine analogs during pelvic surgery: a systematic review. Transfusion
Medicine Reviews. 2014. In Press.
Lavallée LT, Fergusson D, Mallick R, Grenon R, Morgan SC, Momoli F, Witiuk K, Morash C, Cagiannos I, and
Breau RH.
Radiotherapy after Radical Prostatectomy: Treatment
Recommendations Differ between Urologists and
Radiation Oncologists. PLoS ONE 8(11): e79773.
doi:10.1371/journal.pone.0079773. Nov 4, 2013.
Punjani N, Lavallée LT, Momoli F, Fergusson D,
Witiuk K, Mallick R, Morash C, Cagiannos I, and
Breau RH. Blood Transfusion and
Hemostatic Agents used during Radical Cystectomy. Canadian Urological
Association Journal 2013; 7(5-6):e275-80. http://dx.doi.org/10.5489/cuaj.1002
Published online May 13, 2013.
Breau RH, Karnes RJ, Jacobson DJ, McGree ME,
Jacobsen SJ, Nehra A, Lieber MM, and St. Sauver JL. The association between statin
use and the diagnosis of prostate cancer. J. Urol. 2010 184(2): 494-9.
Breau RH, Crispen PL, Jimenez RE, Lohse CM,
Blute ML, and Leibovich BC. Outcome of stage T2 or greater renal cell cancer
treated with partial nephrectomy. J Urol. 2010 Mar;183(3):903-8.
